MustGrow Biologics has received the first milestone payment from Bayer AG under their December 2023 License and Collaboration Agreement. The deal grants Bayer rights to MustGrow's mustard-based biocontrol technologies for soil applications in Europe, the Middle East, and Africa. This initial payment corresponds to technical product development milestones, with potential future payments tied to further achievements and commercial sales royalties. Bayer will handle regulatory, market development, and commercialization efforts in the region, with the total value of upfront and milestone payments plus development work estimated at $35-$40 million over 5 to 7 years. This partnership validates MustGrow's sustainable agricultural technologies and supports their expansion in global markets.
LightInTheBox Holding Co., Ltd., a global consumer lifestyle company, announced it will release its unaudited financial results for the second quarter ended June 30, 2026, on August 26 before the U.S. markets open. The company will hold a conference ...
The Eaton Vance Enhanced Equity Income Fund II (EOS) is currently trading at a rare 10.45% discount, offering an attractive 8.36% yield for income-focused investors. The fund's recent underperformance is mainly due to a widening discount and missing ...
New York City is facing a potential loss of Amazon's delivery services due to a proposed local ordinance that would ban the company from using subcontractors for deliveries. This law is supported by Mayor Zohran Mamdani, the Democratic Socialists of ...
Oakoff Investments downgraded Dell Technologies (DELL) from Buy to Hold before its Q2 2027 earnings report due to concerns that much of the company's growth potential is already priced into the stock. Despite strong growth driven by AI infrastructure...
Strategy's bitcoin holdings have returned to profitability with an unrealized gain of about $1.4 billion after Bitcoin's price rose nearly 22% over five days, recovering from a 54% drop earlier this year. The company holds 840,447 BTC at an average c...
